GemVax&KAEL Co.Ltd (082270) — Cash Flow Reinvestment Rate
GemVax&KAEL Co.Ltd (082270) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting ₩1.48 Billion (capex ₩1.43 Billion plus investments ₩-53.31 Million) from operating cash flow of ₩10.34 Billion. See how much free cash does GemVax&KAEL Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GemVax&KAEL Co.Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for GemVax&KAEL Co.Ltd across 5 annual periods. For the full cash flow conversion analysis, see GemVax&KAEL Co.Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for GemVax&KAEL Co.Ltd (2011–2025)
Year-by-year capital reinvestment analysis for GemVax&KAEL Co.Ltd. See GemVax&KAEL Co.Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.26x | ₩3.61 Billion | ₩1.11 Billion | ₩2.11 Billion | ▼ -38.7% |
| 2023 | 5.32x | ₩18.98 Billion | ₩3.57 Billion | ₩8.46 Billion | ▲ +196.7% |
| 2020 | 1.79x | ₩25.03 Billion | ₩13.95 Billion | ₩10.37 Billion | ▲ +54.1% |
| 2014 | 1.16x | ₩12.38 Billion | ₩10.64 Billion | ₩1.31 Billion | ▲ +174.5% |
| 2011 | 0.42x | ₩3.15 Billion | ₩7.42 Billion | ₩3.15 Billion | — |